FWL Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Sell
4,439
-144
-3% -$49.3K 0.3% 52
2026
Q1
$1.61M Buy
4,583
+24
+0.5% +$8.56K 0.35% 47
2025
Q4
$1.49M Sell
4,559
-95
-2% -$30.1K 0.36% 48
2025
Q3
$1.31M Sell
4,654
-479
-9% -$139K 0.34% 51
2025
Q2
$1.43M Buy
5,133
+445
+9% +$126K 0.44% 45
2025
Q1
$1.46M Sell
4,688
-102
-2% -$30.1K 0.54% 39
2024
Q4
$1.25M Buy
4,790
+431
+10% +$128K 0.45% 49
2024
Q3
$1.4M Buy
4,359
+4,169
+2,194% +$1.36M 0.54% 46
2024
Q2
$59.4K Buy
+190
New +$55.8K 0.03% 98

Other funds holding AMGN

FWL Investment Management's AMGN Position: Q2 2026 in Review

FWL Investment Management reduced its Amgen (AMGN) stake by 3.1% in Q2 2026, selling an estimated $49.3K and leaving 4,439 shares worth $1.61M. The position accounts for 0.3% of the portfolio, ranked #52.

FWL Investment Management first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.61M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • FWL Investment Management held 4,439 shares of Amgen worth $1.61M as of Q2 2026.
  • FWL Investment Management sold 144 Amgen shares in Q2 2026, an estimated $49.3K.
  • Amgen made up 0.3% of FWL Investment Management's portfolio in Q2 2026, its #52 holding.
  • FWL Investment Management first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • FWL Investment Management's Amgen position peaked at $1.61M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.